Botulinum toxin therapy: functional silencing of salivary disorders.

Acta Otorhinolaryngol Ital

Otolaryngology Section, Department of Neuroscience DNS, University of Padova, Italy.

Published: April 2017

Botulinum toxin (BTX) is a neurotoxic protein produced by Clostridium botulinum, an anaerobic bacterium. BTX therapy is a safe and effective treatment when used for functional silencing of the salivary glands in disorders such as sialoceles and salivary fistulae that may have a post-traumatic or post-operative origin. BTX injections can be considered in sialoceles and salivary fistulae after the failure of or together with conservative treatments (e.g. antibiotics, pressure dressings, or serial aspirations). BTX treatment has a promising role in chronic sialadenitis. BTX therapy is highly successful in the treatment of gustatory sweating (Frey's syndrome), and could be considered the gold standard treatment for this neurological disorder.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463526PMC
http://dx.doi.org/10.14639/0392-100X-1608DOI Listing

Publication Analysis

Top Keywords

botulinum toxin
8
functional silencing
8
silencing salivary
8
btx therapy
8
sialoceles salivary
8
salivary fistulae
8
btx
5
toxin therapy
4
therapy functional
4
salivary
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!